Bionow | News

Announcing Pharmora’s first masterclass blog series: Happy Birthday HGR!

Jun 28th 2024

On the first anniversary of the finalisation of the HGR regulations in China, Pharmora has put together a Masterclass of 3 blogs, aimed to help those of us working in clinical development un...

Northern Gritstone invests £2 million in adsilico

Mar 25th 2024

Northern Gritstone has made a £2 million investment into adsilico, a groundbreaking computational medicine company, spunout from the University of Leeds, based on research funded by the Roy...

First patient dosed in Phase 1 Trial

Oct 23rd 2023

Iksuda Therapeutics announces first patient dosed in Phase 1 trial of IKS014 in patients with advanced solid tumours that express HER2

Life science in the era of pandemics: two years on - The new normal in life scie...

Nov 4th 2022

Two years into the pandemic, we consider its impact on the life science sector and how the risk landscape is evolving as the industry builds on the progress it has made.

Are you interested in computational modelling and simulation applied to healthca...

Jun 1st 2022

In Silico trials offer great potential savings in time and money. However, they are not without challenges. Are you developing an In Silico model, or are in the process of using one or have...

Life Science in the era of pandemics: 2 years on

Apr 13th 2022

Final Part of the series: The new normal in life science

Government funding boost for COVID-19 drug testing platform

Feb 16th 2021

The COVID-19 drug testing platform AGILE, co-led by the University of Liverpool, has received a multi-million pound award from the UK government’s Department of Health and Social Care to f...

Liability on the Frontline - Part 1: Emerging risks in Covid-19 clinical trials

Oct 14th 2020

With the scientific community throwing everything it has at Covid-19, best practice is slipping in clinical trials. What trade-offs are being made and who is liable?

Innovative COVID-19 drug testing platform launched

Jul 9th 2020

The University of Liverpool, Liverpool School of Tropical Medicine and Southampton Clinical Trials Unit have announced the launch of an innovative COVID-19 drug testing platform, AGILE.

Vaccine trials among recipients of £20 million coronavirus research investment

Mar 25th 2020

Trials of new coronavirus vaccine among 6 projects to receive share of £20 million.

Corona Virus (COVID-19) Therapeutics: £10 Million Call for Rapid Deployment

Mar 20th 2020

Funding available for the development and testing of therapeutics to treat COVID-19.

Major Liverpool health research services launched

Oct 30th 2019

The University of Liverpool and Liverpool Health Partners (LHP) have developed two significant new initiatives, Liverpool Clinical Trials Centre (LCTC) and LHP – Single Point of Access for...

News